Sort
64,565 grants matching “drug discovery”
Generation and Characterization of Amyotrophic Lateral Sclerosis iPS cells
$1,837,375Jeffrey D Rothstein · Johns Hopkins University · RC2 · FY2010 · NS
NCI-Frederick Support and Technical Services
$1,837,006Douglas R. Lowy · Office Of The Director, Nci · ZIC · FY2010 · CA
The Johns Hopkins Translational Science Team and Consortium for ETCTN Studies
$1,836,359Michael A. Carducci · Johns Hopkins University · UM1 · FY2023 · CA
Targeting Signal Transduction Pathways for Cancer Drug Discovery
$1,835,922Said M Sebti · H. Lee Moffitt Cancer Ctr & Res Inst · P01 · FY2007 · CA
Mechanisms of Resolution of Lung Injury
$1,835,916Asrar B. Malik · University Of Illinois At Chicago · P01 · FY2019 · HL
Mechanisms of Resolution of Lung Injury
$1,835,916Asrar B. Malik · University Of Illinois At Chicago · P01 · FY2017 · HL
Animal Models Of Neuropsychiatric Disorders
$1,835,912Jacqueline N. Crawley · National Institute Of Mental Health · ZIA · FY2009 · MH
PAAR4Kids-Pharmacogenomics of Anticancer Agents Research in Children
$1,835,847Mary V. Relling · St. Jude Children'S Research Hospital · U01 · FY2014 · GM
Mechanisms of Resolution of Lung Injury
$1,835,629Asrar B. Malik · University Of Illinois At Chicago · P01 · FY2016 · HL
Uncovering the genetic mechanisms of the Chromosome 17q21.31 Tau haplotype on neurodegeneration risk in FTD and PSP
$1,834,889Alison M Goate · Icahn School Of Medicine At Mount Sinai · U54 · FY2022 · NS
Mechanisms of Resolution of Lung Injury
$1,834,768Asrar B. Malik · University Of Illinois At Chicago · P01 · FY2015 · HL
Uncovering the genetic mechanisms of the Chromosome 17q21.31 Tau haplotype on neurodegeneration risk in FTD and PSP
$1,834,302Alison M Goate · Icahn School Of Medicine At Mount Sinai · U54 · FY2024 · NS
African American Cardiovascular pharmacogenetic CONsorTium (ACCOuNT): discovery and translation
$1,833,557Minoli A Perera · Northwestern University At Chicago · U54 · FY2018 · MD
Acquisition of 700 MHz NMR for Automated Chemical/Peptide Library Screening
$1,833,339Dale F Mierke · Dartmouth College · S10 · FY2010 · RR
New therapies for liver fibrosis and hyperproliferation in alpha1-AT deficiency
$1,833,329David H Perlmutter · University Of Pittsburgh At Pittsburgh · P01 · FY2014 · DK
Mechanisms of PMN and Endothelial-Mediated Lung Inflammation and Injury
$1,832,559Asrar B. Malik · University Of Illinois At Chicago · P01 · FY2012 · HL
COBRE Center for Antimicrobial Resistance and Therapeutic Discovery
$1,832,044Erika M D'agata · Miriam Hospital · P20 · FY2022 · GM
Malaria Drug Resistance and Disease Virulence
$1,831,844Thomas E Wellems · National Institute Of Allergy And Infectious Diseases · ZIA · FY2025 · AI
Genetics of Parkonsonism
$1,831,161Jeffery M. Vance · University Of Miami School Of Medicine · P50 · FY2012 · NS
Bioanalysis, Drug Metabolism and New Drug Discovery
$1,830,128Josephine Earley · National Institute On Aging · ZIA · FY2019 · AG
Uncovering the Genetic Mechanisms of the Chromosome 17q21.31 Tau Haplotype on Neurodegeneration Risk in FTD and PSP
$1,827,905Alison M Goate · Icahn School Of Medicine At Mount Sinai · U54 · FY2025 · NS
Basic Dopamine Transporter Mechanisms Of Cocaine
$1,827,786Jonathan L Katz · National Institute On Drug Abuse · Z01 · FY2007 · DA
Development of an M1 PAM experimental therapeutic for schizophrenia
$1,827,730P Jeffrey Conn · Vanderbilt University · U19 · FY2016 · MH
SPORE in Prostate Cancer
$1,827,641William George Nelson · Johns Hopkins University · P50 · FY2016 · CA
NORMAL & NEOPLASTIC GROWTH IN THE BRAIN
$1,827,591Suzanne J Baker · St. Jude Children'S Research Hospital · P01 · FY2022 · CA